Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
2
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Doppler Ultrasound in Vascular Access care: the pearls and pitfalls of flow volume measurement

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Vascular access (VA) care is a critical part of the management of end-stage renal disease. Optimal care is necessary to avoid underdialysis and VA loss, leading to increased morbidity, mortality, and health-care-associated costs. The cornerstone of VA surveillance is flow volume (Qa) measurement. One of the most common ways to quantify Qa in clinical practice is by using duplex ultrasound (DUS), which is based on the Doppler method. DUS is a cheap and non-invasive technology that allows direct Qa measurement and the simultaneous visualization of the VA morphology, which allows the diagnosis of underlying lesions. In addition, DUS has a similar precision to Ultrasound Dilution (UD) methods. On the other hand, DUS is an operator-dependent technique, has more potential measurement errors, is time-consuming, and also loses accuracy in higher Qa. This narrative review aims to discuss the theory and technical considerations behind DUS, as well as its advantages, disadvantages, and pitfalls. We also review the reliability of DUS measurement and its correlation with UD methods. Finally, we reflect on the role of DUS Qa measurements in arteriovenous fistula maturation and surveillance. Despite the overall quality of data regarding VA surveillance not being high, we believe that DUS will remain one of the most important tools at our disposal in every step of VA care.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: not found
          • Article: not found

          EBPG on Vascular Access.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.

            Care of patients with end-stage renal disease (ESRD) is important and resource intense. To enable ESRD programs to develop strategies for more cost-efficient care, an accurate estimate of the cost of caring for patients with ESRD is needed. The objective of our study is to develop an updated and accurate itemized description of costs and resources required to treat patients with ESRD on dialysis therapy and contrast differences in resources required for various dialysis modalities. One hundred sixty-six patients who had been on dialysis therapy for longer than 6 months and agreed to enrollment were followed up prospectively for 1 year. Detailed information on baseline patient characteristics, including comorbidity, was collected. Costs considered included those related to outpatient dialysis care, inpatient care, outpatient nondialysis care, and physician claims. We also estimated separately the cost of maintaining the dialysis access. Overall annual cost of care for in-center, satellite, and home/self-care hemodialysis and peritoneal dialysis were US $51,252 (95% confidence interval [CI], 47,680 to 54,824), $42,057 (95% CI, 39,523 to 44,592), $29,961 (95% CI, 21,252 to 38,670), and $26,959 (95% CI, 23,500 to 30,416), respectively (P < 0.001). After adjustment for the effect of other important predictors of cost, such as comorbidity, these differences persisted. Among patients treated with hemodialysis, the cost of vascular access-related care was lower by more than fivefold for patients who began the study period with a functioning native arteriovenous fistula compared with those treated with a permanent catheter or synthetic graft (P < 0.001). To maximize the efficiency with which care is provided to patients with ESRD, dialysis programs should encourage the use of home/self-care hemodialysis and peritoneal dialysis. Copyright 2002 by the National Kidney Foundation, Inc.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Early arteriovenous fistula failure: a logical proposal for when and how to intervene.

              A significant number of arteriovenous fistulae (28 to 53%) never mature to support dialysis. Often, renal physicians and surgeons wait for up to 6 months and even longer hoping that the arteriovenous fistula (AVF) will eventually grow to support dialysis before declaring that the AVF has failed. In the interim, if dialysis is needed, then a tunneled catheter is inserted, exposing the patient to the morbidity and mortality associated with the use of this device. In general, a blood flow of 500 ml/min and a diameter of at least 4 mm are needed for an AVF to be adequate to support dialysis therapy. In most successful fistulae, these parameters are met within 4 to 6 wk. Most important, commonly encountered problems (stenosis and accessory veins) that result in early AVF failure can be diagnosed easily with skillful physical examination. Recent studies have indicated that a great majority of fistulae that have failed to mature adequately can be salvaged by percutaneous interventions and become available for dialysis. Early intervention regarding identification and salvage of a nonmaturing AVF is critical for several reasons. First, an AVF is the best available type of access regarding complications, costs, morbidity, and mortality. Second, this approach minimizes catheter use and its associated complications. Finally, access stenosis is a progressive process and eventually culminates in complete occlusion, leading to access thrombosis. In this context, the opportunity to salvage the AVF that fails early may be lost. This report reviews the process of AVF maturation and suggests a strategy for when and how to intervene to identify and salvage AVF with early failure.
                Bookmark

                Author and article information

                Journal
                nep
                Portuguese Journal of Nephrology & Hypertension
                Port J Nephrol Hypert
                Sociedade Portuguesa de Nefrologia (Lisboa, , Portugal )
                0872-0169
                March 2020
                : 34
                : 1
                : 36-41
                Affiliations
                [1] Oporto orgnameCentro Hospitalar e Universitário de São João orgdiv1Nephrology Department Portugal
                [2] Oporto orgnameUniversidade do Porto orgdiv1Instituto de Investigação e Inovação em Saúde orgdiv2Nephrology & Infectious Diseases Portugal
                [3] Oporto orgnameUniversity of Oporto orgdiv1Faculty of Medicine Portugal
                Article
                S0872-01692020000100007 S0872-0169(20)03400100007
                10.32932/pjnh.2020.04.061
                32913457-c5e9-4018-bbec-8d2ec5b5bbc3

                This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

                History
                : 11 November 2019
                : 12 December 2019
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 59, Pages: 6
                Product

                SciELO Portugal

                Categories
                Review Articles

                Doppler Ultrasonography,Hemodialysis,Vascular Access,Blood Flow Volume,Arteriovenous Fistula

                Comments

                Comment on this article